📰 Reverse Transcriptase Inhibitors News
Page 2 - Reverse Transcriptase Inhibitors News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reverse Transcriptase Inhibitors. Real-time updates on events, politics, business and more.
October 25, 2022
The Business Research Company’s Coronavirus (COVID-19) Current Therapy Market 2022 - Opportunities And Strategies – Global Forecast To 2031
October 17, 2022
The Business Research Companys HIV Drugs Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
October 12, 2022
First presentation of RSV Older Adult vaccine candidates pivotal phase III efficacy and safety data New data showing Shingrix... | October 12, 2022
September 21, 2022
/PRNewswire/ -- The "Global HIV/AIDS Drugs Market (2022-2027) by Medication Class, Distribution Channel, Geography, Competitive Analysis and the Impact of...
September 19, 2022
The Business Research Company’s Antivirals Global Market Report 2022: Market Size, Trends And Forecast To 2026
September 9, 2022
[300 Pages Report] The global HIV antivirals market is expected to be worth $30.6 billion in 2022, with a CAGR of 4.4 percent during the forecast period (2022-2032). According to a recent study, fixed-dose combinations (FDCs) will account for more than 83 percent of the HIV antivirals market in 2021.According to Fut...
June 24, 2022
The Business Research Company’s COVID-19 Current Therapy Market 2022 – Opportunities And Strategies – Global Forecast To 2030
June 6, 2022
The Business Research Company’s Remdesivir Global Market Report 2022: Market Size, Trends, And Forecast To 2026
May 30, 2022
/PRNewswire/ -- A comprehensive overview of the Antiviral Drugs Market is recently added by UnivDatos Market Insights to its humongous database. The report has...
May 5, 2022
TBRC's market report goes into detail on competitive landscape, strategy, regional analysis, and beyond. LONDON, May 5, 2022 /PRNewswire/ -- The influenza diagnostic market is highly fragmented